Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
[Preprint]. 2023 Oct 27:2023.10.26.564222.
doi: 10.1101/2023.10.26.564222.

Altered PBP4 and GdpP functions synergistically mediate MRSA-like high-level, broad-spectrum β-lactam resistance in Staphylococcus aureus

Affiliations

Altered PBP4 and GdpP functions synergistically mediate MRSA-like high-level, broad-spectrum β-lactam resistance in Staphylococcus aureus

Li-Yin Lai et al. bioRxiv. .

Update in

Abstract

Infections caused by Staphylococcus aureus are a leading cause of mortality worldwide. S. aureus infections caused by Methicillin-Resistant Staphylococcus aureus (MRSA) are particularly difficult to treat due to their resistance to Next Generation β-lactams (NGB) such as Methicillin, Nafcillin, Oxacillin etc. Resistance to NGBs, which is alternatively known as broad-spectrum β-lactam resistance is classically mediated by PBP2a, a Penicillin-Binding Protein encoded by mecA (or mecC) in MRSA. Thus, presence of mec genes among S. aureus serves as the predictor of resistance to NGBs and facilitates determination of the proper therapeutic strategy for a staphylococcal infection. Although far less appreciated, mecA deficient S. aureus strains can also exhibit NGB resistance. These strains, which are collectively termed as Methicillin-Resistant Lacking mec (MRLM) are currently being identified in increasing numbers among natural resistant isolates of S. aureus. The mechanism/s through which MRLMs produce resistance to NGBs remains unknown. In this study, we demonstrate that mutations that alter PBP4 and GdpP functions, which are often present among MRLMs can synergistically mediate resistance to NGBs. Furthermore, our results unravel that this novel mechanism potentially enables MRLMs to produce resistance towards NGBs at levels comparable to that of MRSAs. Our study, provides a fresh new perspective about alternative mechanisms of NGBs resistance, challenging our current overall understanding of high-level, broad-spectrum β-lactam resistance in S. aureus. It thus suggests reconsideration of the current approach towards diagnosis and treatment of β-lactam resistant S. aureus infections.

Keywords: Methicillin-Resistant Lacking mec (MRLM); gdpP; pbp4; β-lactam resistance.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.. GdpP and PBP4 mutations that were identified in MRLM isolates.
(A) Venn diagram describing occurrence pbp4 and/or gdpP mutations in MRLM strains described in previous studies. (B) Venn diagram describing the occurrence of pbp4 regulatory site associated and/or missense mutations in MRLM strains described previously (C) Schematic diagram of pbp4 and abcA genes separated by a 420 bp intergenic, regulatory site region. (D) Illustration and distribution of gdpP-associated mutations (INDELs, missense and nonsense) detected in MRLM isolates. gdpP-associated mutations were further classified based on location of mutation with respect to the DHH/DHHA1 catalytic domain. (E) Schematic representation of different domains in the gdpP gene. The phosphodiesterase catalytic activity of GdpP is mediated by its DHH/DHHA1 domains.
Figure 2.
Figure 2.. Phenotypic characterization of the strains used in this study.
(A) List of strains used for obtaining the results for sub figures B-E. (B) Immunoblotting to detect PBP2a (α-PBP2a, 76.1 kDa, upper panel) was present in only lane 1 (Wt) and Sortase-A (α-SrtA, lower panel) as a loading control that was detected for all samples. “M” represents Protein Molecular Weight Marker. (C) Nitrocefin disk test indicated that only Wt had β-lactamase activity, as seen by the color change of the disk from yellow to red. Color of the disks streaked with other strains remained unchanged. (D) Bocillin assay to detect PBPs 1 through 4. Strains with pbp4 regulatory site mutations (lanes 4 and 5) showed enhanced PBP4 expression compared to the isogenic Wtex strain (lane 2). Strains with the pbp4 S75A mutation (lanes 6 and 7) did not show any PBP4 band. ΔgdpP (lanes 5 and 7) did not have an effect on expression of PBPs. PBP expression levels were visualized by the Typhoon 9410 imager (Amersham/GE Healthcare). (E) Measurement of intracellular levels of CDA for the studied strains. Strains with the ∆gdpP mutation show high levels of CDA compared to their isogenic pairs. P-value = 0.0003 for Wtex versus Wtex ΔgdpP; P-value < 0.0001 for Wtex Ppbp4* pbp4** versus Ppbp4* pbp4** ΔgdpP, and Wtex Ppbp4* pbp4** S75A versus Wtex Ppbp4* pbp4** S75A ΔgdpP.
Figure 3:
Figure 3:. pbp4 mutations and deletion of gdpP synergistically mediate high-level β-lactam resistance in S. aureus.
Population analysis with (A) Nafcillin and (B) Oxacillin. The triple mutant, Wtex Ppbp4* pbp4** ΔgdpP (blue squares) had increased survival compared to Wtex (pink squares), Wtex ΔgdpP (beige squares) and Wtex Ppbp4* pbp4** (green squares). Resistance displayed by the triple mutant was comparable to that displayed by Wt (red squares). Functional mutation of pbp4 due to introduction of S75A (Wtex Ppbp4* pbp4** S75A, black squares and Wtex Ppbp4* pbp4** S75A ΔgdpP, grey squares) resulted in NGB susceptibility.
Figure 4.
Figure 4.. Complementation of gdpP restored β-lactam susceptibility of the NGB resistant triple mutant.
Population analysis of complemented strains carried out with (A) Nafcillin and (B) Oxacillin. Complementation of the triple mutant with a functional GdpP (Wtex Ppbp4* pbp4** ΔgdpP [gdpP], empty blue squares) resulted is a loss of high-level resistance, in a profile similar to Wtex Ppbp4* pbp4** [E] (filled green squares). Complementation of the triple mutant with an empty vector (Wtex Ppbp4* pbp4** ΔgdpP [E], filled blue squares) preserved the resistant phenotype associated with the mutations. (C) Measurement of intracellular levels of CDA for complemented strains. Complementation of the triple mutant with a functional GdpP (Wtex Ppbp4* pbp4** ΔgdpP [gdpP], empty blue squares) led to decreased levels of CDA within cells that was similar to Wtex Ppbp4* pbp4** [E] (filled green squares), whereas complementation of the triple mutant with an empty vector (Wtex Ppbp4* pbp4** ΔgdpP [E], filled blue squares) maintained high levels of CDA.
Figure 5:
Figure 5:. Alteration of GdpP does not affect the composition of the cell wall.
Muropeptide purification and analysis profiles of (A) Wt, Wtex and Wtex Ppbp4* pbp4** (B) Wtex and Wtex ΔgdpP (C) Wtex Ppbp4* pbp4** and Wtex Ppbp4* pbp4** ΔgdpP. pbp4-associated mutations led to increased cell wall cross-linking (increased levels of peak 12 and peak 18+ i.e. the “hump”) compared to Wtex. This increase was independent of ΔgdpP. Similarly, deletion of gdpP did not contribute to any significant alterations in the cell wall, irrespective of the presence of pbp4-associated mutations.
Figure 6.
Figure 6.. Deletion of gdpP led to NGB tolerance in S. aureus.
TD-test analysis to estimate tolerance levels in S. aureus strains. (A-B) TD-test with Nafcillin. (C-D) TD-test with Oxacillin. CFUs in the 50% inhibition zone of the strains containing gdpP deletion, namely Wtex ΔgdpP and Wtex Ppbp4* pbp4** ΔgdpP are higher compared to their isogenic strains with a functional GdpP, namely Wtex and Wtex Ppbp4* pbp4**. All data are from three independent experiments and presented as mean ± SD with One-Way ANOVA (***: P-value ≤ 0.001, **: P-value ≤ 0.01).
Figure 7.
Figure 7.. Synergistic action of PBP4 and GdpP alterations resulted in NGB therapy failure.
Percent survival of C. elegans when infected with bacteria over a period of 72h in presence of (A) 4 mg/L (B) 8 mg/L or (C) 16 mg/L Nafcillin. Worms infected with Wtex had 100% survival, whereas infection with Wtex Ppbp4* pbp4** ΔgdpP had decreased survival, similar to that seen by Wt. (D) The triple mutant, Wtex Ppbp4* pbp4** ΔgdpP had attenuated virulence compared to Wt and Wtex the the absence of Nafcillin. Worms infected with OP50, the E. coli control, showed 100% worm survival. Enumeration of bacterial load within the gut of C. elegans in presence of (E) 4 mg/L (F) 8 mg/L or (G) 16 mg/L Nafcillin. Compared to Wtex, which was was not detected, Wt and Wtex Ppbp4* pbp4** ΔgdpP had significant colonization within the gut. (H) Gut bacterial enumeration when infection was carried out without Nafcillin indicated that Wt, Wtex and Wtex Ppbp4* pbp4** ΔgdpP had similar colonization abilities. (***: P-value ≤ 0.001, and **: P-value ≤ 0.01, P-value ≤ 0.05, ns = P-value > 0.05)
Figure 8.
Figure 8.. Growth assay in presence of Ceftaroline.
Treatment of Wt, Wtex and Wtex Ppbp4* pbp4** ΔgdpP in increasing concentrations of Ceftraroline (0–0.5 mg/L) demonstrated that Wt and Wtex were susceptible to Ceftaroline. However, and Wtex Ppbp4* pbp4** ΔgdpP was not susceptible to the drug and survived even in presence of the highest concentration of the drug.

References

    1. Sakr A, Brégeon F, Mège J-L, Rolain J-M, Blin O. 2018. Staphylococcus aureus Nasal Colonization: An Update on Mechanisms, Epidemiology, Risk Factors, and Subsequent Infections. Frontiers in Microbiology 9. - PMC - PubMed
    1. Chambers HF, Deleo FR. 2009. Waves of resistance: Staphylococcus aureus in the antibiotic era. Nature Publishing Group 7:629–641. - PMC - PubMed
    1. Bui LMG, Conlon Brian P, Kidd Stephen P. 2017. Antibiotic tolerance and the alternative lifestyles of Staphylococcus aureus. Essays in Biochemistry 61:71–79. - PubMed
    1. Murray CJL, Ikuta KS, Sharara F, Swetschinski L, Robles Aguilar G, Gray A, Han C, Bisignano C, Rao P, Wool E, Johnson SC, Browne AJ, Chipeta MG, Fell F, Hackett S, Haines-Woodhouse G, Kashef Hamadani BH, Kumaran EAP, McManigal B, Achalapong S, Agarwal R, Akech S, Albertson S, Amuasi J, Andrews J, Aravkin A, Ashley E, Babin F-X, Bailey F, Baker S, Basnyat B, Bekker A, Bender R, Berkley JA, Bethou A, Bielicki J, Boonkasidecha S, Bukosia J, Carvalheiro C, Castañeda-Orjuela C, Chansamouth V, Chaurasia S, Chiurchiù S, Chowdhury F, Clotaire Donatien R, Cook AJ, Cooper B, Cressey TR, Criollo-Mora E, Cunningham M, et al. 2022. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. The Lancet 399:629–655. - PMC - PubMed
    1. Bush K, Bradford PA. 2016. β-Lactams and β-Lactamase Inhibitors: An Overview. Cold Spring Harb Perspect Med 6. - PMC - PubMed

Publication types